Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
124417533 | 12441753 | 3 | F | 201210 | 20160917 | 20160607 | 20160926 | EXP | US-DSJP-DSU-2015-133866 | DAIICHI | 0.00 | Y | 0.00000 | 20160924 | MD | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
124417533 | 12441753 | 1 | PS | BENICAR | OLMESARTAN MEDOXOMIL | 1 | UNK | Y | 21286 | TABLET | |||||||||
124417533 | 12441753 | 2 | SS | BENICAR | OLMESARTAN MEDOXOMIL | 1 | 20 MG, QD | Y | 21286 | 20 | MG | TABLET | QD | ||||||
124417533 | 12441753 | 3 | SS | BENICAR HCT | HYDROCHLOROTHIAZIDEOLMESARTAN MEDOXOMIL | 1 | 40/25 MG ONE HALF TABLET, QD | U | 0 | FILM-COATED TABLET | QD | ||||||||
124417533 | 12441753 | 4 | SS | BENICAR HCT | HYDROCHLOROTHIAZIDEOLMESARTAN MEDOXOMIL | 1 | 20MG/12.5MG, UNK | U | 0 | 1 | DF | FILM-COATED TABLET | |||||||
124417533 | 12441753 | 5 | C | ASPIRIN /00002701/ | ASPIRIN | 1 | UNK | 0 | |||||||||||
124417533 | 12441753 | 6 | C | BYSTOLIC | NEBIVOLOL HYDROCHLORIDE | 1 | 20 MG, QD | 0 | 20 | MG | QD | ||||||||
124417533 | 12441753 | 7 | C | LASIX | FUROSEMIDE | 1 | 20 MG, QD | 0 | 20 | MG | QD | ||||||||
124417533 | 12441753 | 8 | C | LISINOPRIL. | LISINOPRIL | 1 | 20 MG, QD | 0 | 20 | MG | QD | ||||||||
124417533 | 12441753 | 9 | C | ZOFRAN | ONDANSETRON HYDROCHLORIDE | 1 | 4 MG, PRN | 0 | 4 | MG | |||||||||
124417533 | 12441753 | 10 | C | LEVAQUIN | LEVOFLOXACIN | 1 | Oral | 750 MG, QD | 0 | 750 | MG | QD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
124417533 | 12441753 | 1 | Hypertension |
124417533 | 12441753 | 3 | Product used for unknown indication |
124417533 | 12441753 | 5 | Product used for unknown indication |
124417533 | 12441753 | 6 | Product used for unknown indication |
124417533 | 12441753 | 7 | Product used for unknown indication |
124417533 | 12441753 | 8 | Product used for unknown indication |
124417533 | 12441753 | 9 | Nausea |
124417533 | 12441753 | 10 | Pneumonia |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
124417533 | 12441753 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
124417533 | 12441753 | Acute kidney injury | |
124417533 | 12441753 | Constipation | |
124417533 | 12441753 | Gastrooesophageal reflux disease | |
124417533 | 12441753 | Haematochezia | |
124417533 | 12441753 | Hiatus hernia | |
124417533 | 12441753 | Malabsorption | |
124417533 | 12441753 | Wrong technique in product usage process |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
124417533 | 12441753 | 1 | 2012 | 201502 | 0 | |
124417533 | 12441753 | 2 | 20130228 | 20130307 | 0 | |
124417533 | 12441753 | 3 | 20140707 | 0 | ||
124417533 | 12441753 | 4 | 20130307 | 0 | ||
124417533 | 12441753 | 6 | 20121022 | 0 | ||
124417533 | 12441753 | 7 | 20121022 | 0 | ||
124417533 | 12441753 | 8 | 20121022 | 0 | ||
124417533 | 12441753 | 9 | 20121022 | 0 | ||
124417533 | 12441753 | 10 | 20121022 | 0 |